Compare QLYS & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | QLYS | BLCO |
|---|---|---|
| Founded | 1999 | 1853 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Ophthalmic Goods |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 6.0B |
| IPO Year | 2012 | 2022 |
| Metric | QLYS | BLCO |
|---|---|---|
| Price | $130.90 | $16.56 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 15 | 14 |
| Target Price | ★ $139.43 | $17.31 |
| AVG Volume (30 Days) | ★ 416.5K | 334.3K |
| Earning Date | 02-05-2026 | 02-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 13.91 | N/A |
| EPS | ★ 5.16 | N/A |
| Revenue | $653,034,000.00 | ★ $4,976,000,000.00 |
| Revenue This Year | $12.00 | $8.06 |
| Revenue Next Year | $7.68 | $5.79 |
| P/E Ratio | $25.40 | ★ N/A |
| Revenue Growth | ★ 10.13 | 6.23 |
| 52 Week Low | $112.61 | $10.45 |
| 52 Week High | $155.47 | $18.55 |
| Indicator | QLYS | BLCO |
|---|---|---|
| Relative Strength Index (RSI) | 30.31 | 48.64 |
| Support Level | $131.00 | $16.94 |
| Resistance Level | $140.74 | $17.26 |
| Average True Range (ATR) | 3.85 | 0.31 |
| MACD | -1.79 | -0.07 |
| Stochastic Oscillator | 6.78 | 2.74 |
Qualys is a cloud security and compliance solutions provider that helps businesses identify and manage their security risks and compliance requirements. The California-based company has more than 10,000 customers worldwide, the majority of which are small- and medium-size businesses. Qualys was founded in 1999 and went public in 2012.
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.